Cannabis Stocks News
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Equipment >

Arrayit Corporation (ARYC)

Add ARYC Price Alert      Hide Sticky   Hide Intro
Moderator: TREND1, techmover, Penny Traders Club, Top Penny, bz777, whento
Search This Board: 
Last Post: 9/19/2017 10:13:23 PM - Followers: 448 - Board type: Free - Posts Today: 190



ARYC is a Silicon Valley company that is currently trading under a penny per share but not for much longer. Sales of its microarray products are in excess of $30,000 to $40,000 per day!! Please research this Silicon Valley company. This company has potential of trading in excess of $5 per share:


Follow  @Arrayit and $ARYC on Twitter


Arrayit Corporation on Facebook 


No share increase per CEO.....!!!!!..  AND......Trading at .6x earnings....... Yes, point 6 times!

Estimated earnings of $8 million last year and it is also located in the heart of Silicon Valley near Apple, Yahoo, AMD, Juniper, MBZ, LinkedIn, Facebook and many, many other leaders of the tech industry. 


Trading at an incredibly low share price under a penny.


2 contracts signed last year for a total of approximately $51 million over the next 3 years ......


No other sub penny company has the potential of ARYC  


Please check out their tweets @Arrayit or go to their Facebook page: Arrayit Corporation 




Please check their products that are selling in the tens of thousands of dollars daily. 


Link to their products:


Arrayit's new corporate headquarters, located at 927 Thompson Place, Sunnyvale, California, 94085, feature 15,000 square feet of modern industrial space including 45 parking spaces, offices, conference rooms, demonstration laboratories, class 100 cleanrooms, and manufacturing and shipping facilities.


ARYC is continuing  a strong and steady move up on steady  volume.  Please take some time to review the ARYC board with due diligence done by investors.



Arrayit reports $46,000 microarray services sale to a leading proteomics research company located in the central USA 

(link: ;… 


Arrayit signs 3-year $24.4 million patented microarray technology sales and marketing agreement with a leading laboratory services provider.


ARYC: Arrayit Corporation 


@Arrayit on Twitter 


Link to their products:


ARYC also owns 40 million shares of AVDX. A value of $12 million +


Arrayit wins technical specification bid on $110,000 microarray instrument government tender with top life sciences distributor in India.


$ARYC.....Arrayit on-line company Store sales exceed $54.5 million all-time on 226,285 microarray products and services sold



Corporate Overview

Arrayit Corporation is a leading life sciences company providing innovative products and services to empower scientists and clinicians to explore the human genome as well as the genomes of plants and animals. Arrayit's worldwide business position leverages the company's widely used patented microarray manufacturing platform and revolutionary VIP™ genotyping technology. Nearly every major research center in the world uses Arrayit products including research laboratories, pharmaceutical companies, universities, biotechnology companies, hospitals, government agencies, and nonprofit research organizations. Novel insights into the function of genes and proteins, early stage disease diagnostics, better and safer medicines, and more nutritional crop plants are some of the many aspects of human health empowered by Arrayit technology.

Corporate Philosophy
Arrayit is an exciting and innovative public company that strives to increase shareholder equity by inventing, developing, manufacturing and supplying sophisticated life sciences products and services to an extensive customer base spanning 50 countries.
Our corporate philosophy is embodied by a highly skilled, multidisciplinary team of investors, business professionals, scientists, engineers and executive and support staff who place shareholder value, product quality, customer service and price competitiveness as our highest priorities. Arrayit empowers decisive strategic advantage and large return on investment for our customers in the research, pharmaceutical, diagnostic, and health care markets.

Corporate History
Arrayit Corporation was founded in 1993 by Rene' Schena and Todd Martinsky as TeleChem International, Inc, a chemical import and export company specializing in plastics, water soluble fertilizers, alternative fuels, and the life sciences. After several years of successful revenues growth, the company expanded in 1999 by adding Dr. Mark Schena and Paul Haje, who together with Ms. Schena and Mr. Martinsky, founded Arrayit Life Sciences, a division of TeleChem International, Inc. Arrayit sought to build on the opportunities created by the deciphering of the human genome and the rise of microarray technology. Arrayit microarrays are sophisticated glass substrates containing large collections of DNA and protein spots that allow all 25,000 human genes and every major protein in the human body to be analyzed in a few hours. Arrayit VIP™ microarrays enable the analysis of the DNA from 100,000 patients in one day. Since 1999, Arrayit has has build a powerful portfolio of patents, trade secrets, and more than 650 life sciences products. The company was featured on the television series
NOVA in 2001, received successive appointments to the Inc. 500 list in 2002 and 2003, and has received numerous local awards including the Rising Star award from the City of Sunnyvale and the
Silicon Valley 50 award in 2003. The company changed its name to Arrayit Corporation and began trading on the OTC Bulletin Board in 2009 as ticker symbol ARYC. The company's products and services are used in the life sciences, pharmaceutical, and diagnostics markets, which are estimated at $690 billion in annual revenue.


OvaDx® Ovarian Cancer Diagnostic Test

In Development

Arrayit Diagnostics, Inc. provides the market's first large panel biomarker screening test for ovarian cancer. OvaDx® is a sophisticated microarray-based test that measures the activation of the immune system in blood samples in response to early stage ovarian tumor cell development. Research studies with OvaDx® indicate high sensitivity and specificity for all types and stages of ovarian cancer including stage IA-IV borderline serous, clear cell, endometrioid, mixed epithelial, mucinous, serous, and ovarian adenocarcinoma. Upon FDA approval, Arrayit Diagnostics will offer OvaDx® as an elective test for women seeking greater wellness and for women in the elevated risk category for ovarian cancer. OvaDx® will be used by doctors to advance the forefront of ovarian cancer treatment including improved surgical options, more effective chemotherapies, and to supplement existing tests including CA-125, OVA1®, and transvaginal ultrasound.


Diagnostics - Parkinson's Disease

Parkinsons Disease
Arrayit has leveraged the company's patented and proprietary microarray discovery platform to decipher the molecular basis of Parkinson's Disease (PD). This important research project, completed as a collaboration with The Parkinson's Institute (Sunnyvale, California), offers exciting promise for the pre-symptomatic and post-symptomatic diagnosis and treatment of this serious neurodegenerative condition. Arrayit is currently seeking a strategic partner to accelerate FDA approval of the Arrayit PDx™ Parkinson's Disagnostic Test, speed the benchmarking of PDx™ as a companion diagnostic, and determine and enhance the efficacy of pipeline therapeutic proteins and small molecules.


Avant Diagnostics, Inc.

Definitive diagnostic screening test for early stage detection



About Avant Diagnostics, Inc.


Avant Diagnostics, Inc., ("AD") previously named Arrayit Diagnostics, Inc., is a Nevada corporation presently a majority-owned subsidiary of Arrayit Corporation ("Arrayit"). AD's business is based upon the completion of the human genome sequencing project. Genetic research is increasingly focused on identifying the variations of the specific genes in the genome. These variations are what define individual characteristics, including disease states or a statistical propensity for disease. The implications are far-reaching and impact not only the research community, but also the individual patients and the medical providers. Diagnostic tests that detect diseases very early in their progression will provide options for earlier treatments that may improve the patient's quality of life and prognosis by delaying or preventing disease progression or even death. Medical providers will incur major cost savings by avoiding costly late stage disease treatments.


© 2013 by Avant Diagnostics, Inc., all rights reserved.

Related Articles

Cannabis Stocks News
Interactive Brokers Advertisement
Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
#54190  Sticky Note For those who are new to the board: whento 08/25/17 03:16:15 PM
#47743  Sticky Note Ladies and Gentlemen, as incredulous as it may spotlight1 06/29/17 01:44:26 PM
#46478  Sticky Note We expect an immediate share price increase upon techmover 05/25/17 05:24:04 PM
#42929  Sticky Note ***Ten Reasons To Invest in Arrayit Corporation (ARYC)*** Penny Traders Club 04/01/17 11:54:57 AM
#56174   What trial? Liuhisn 09/19/17 10:13:23 PM
#56172   Got it... Doesn't have to be the kod The_Free_Nebula 09/19/17 08:32:16 PM
#56170   Absolutely agree! Hope for before but I'm long Toofast 09/19/17 08:31:15 PM
#56169   Thanx... The_Free_Nebula 09/19/17 08:30:44 PM
#56168   Agree Penny Traders Club 09/19/17 08:20:04 PM
#56165   ARYC...OK...some of you guys/gals won't accept...Financials won't appear tm1119 09/19/17 08:16:56 PM
#56164   so is "financials are coming". lucky,mydog 09/19/17 08:13:30 PM
#56163   lololol. it's been "in process" for too long. lucky,mydog 09/19/17 08:12:51 PM
#56162   This is old news Penny Traders Club 09/19/17 08:12:26 PM
#56161   That list is correct but ARYC is in Penny Traders Club 09/19/17 08:11:21 PM
#56160   ARYC...RIGHT ON!!!!....You are SO RIGHT!!!...GLTA!!$$$$$$ tm1119 09/19/17 08:09:53 PM
#56159   ARYC...Excuse me...DAM RIGHT THERE IS!!...Trial Date October...GLTA tm1119 09/19/17 08:05:21 PM
#56157 lucky,mydog 09/19/17 07:45:46 PM
#56156   Hold long financials are coming! Penny Traders Club 09/19/17 07:26:57 PM
#56155   Do you own DD Penny Traders Club 09/19/17 07:16:05 PM
#56154   if (and that's a big IF) the plaintiff MikeCr 09/19/17 07:04:35 PM
#56153   Agreed. Common among businesses, and the majority of SK510 09/19/17 06:49:39 PM
#56152   Yes there are however according to the CEO Toofast 09/19/17 06:45:39 PM
#56150   Are there pending lawsuits? The_Free_Nebula 09/19/17 06:30:46 PM
#56147   I was looking for a real reason why The_Free_Nebula 09/19/17 06:16:53 PM
#56145   They're aren't millionaires, nowhere near. They're desperate, facing Full Contact Yoga 09/19/17 06:02:32 PM
#56144   Why would think they are fraudulent? Likely, they Toofast 09/19/17 05:55:34 PM
#56143   Makes no difference, Schena's tweets are meaningless and Full Contact Yoga 09/19/17 05:39:40 PM
#56142   Show me the date of your tweet. MikeCr 09/19/17 05:35:26 PM
#56141   WRONG!! Arrayit reports $115K microarray sale to top Toofast 09/19/17 05:34:06 PM
#56140   More green days to come!!!! 0cash 09/19/17 05:29:04 PM
#56139   Arrayit's management relationship with the Houston group, of MikeCr 09/19/17 05:27:57 PM
#56137   Wrong! It was $15K NOT $115K as you report MikeCr 09/19/17 04:54:35 PM
#56136   Nice day! Big buys Fireman451 09/19/17 04:12:25 PM
#56135   Welcome themanz1 glad to have you! Toofast 09/19/17 04:07:50 PM
#56134   Any Green Day is a good day! Penny Traders Club 09/19/17 04:04:12 PM
#56133   welcome aboard. great to have you here. You themanz. whento 09/19/17 03:58:51 PM
#56132   Welcome to the board Manz1 :) UndervaluedStocks 09/19/17 03:56:00 PM
#56131   Welcome Brother you won't regret it Penny Traders Club 09/19/17 03:55:12 PM
#56130   It's me I'm new to the board but themanz1 09/19/17 03:54:36 PM
#56129   Someone slap that ask Penny Traders Club 09/19/17 03:53:29 PM
#56128   we are coming into the homestretch. Investors taking whento 09/19/17 03:49:50 PM
#56127   Soon these cheap shares will be history. Jeffpacman 09/19/17 03:49:36 PM
#56126   New investors joining every day :-) Penny Traders Club 09/19/17 03:39:42 PM
#56125   Could be our buddy GBI Toofast 09/19/17 03:32:07 PM
#56124   Great investment here! Excited about the potential for Toofast 09/19/17 03:30:25 PM
#56123   Strong close here HotStockAlerts 09/19/17 03:30:10 PM
#56122   Good is an understatement HotStockAlerts 09/19/17 03:18:01 PM
#56121   Tweets aside, I believe we will be in whento 09/19/17 03:14:20 PM
#56120   They have had a lot of big conference TravO 09/19/17 03:11:33 PM
#56119   Agree, I have seen that new equip supposed Penny Traders Club 09/19/17 03:06:17 PM
#56118   Don't forget about all the tweets about upping TravO 09/19/17 03:02:51 PM
#56117   Next month someone will deeply regret them UndervaluedStocks 09/19/17 03:02:23 PM
#56116   6 sales reported so far today ;) TravO 09/19/17 03:01:15 PM
#56115   My family and I are holding long and strong!!!!!! Penny Traders Club 09/19/17 03:00:54 PM